✦ LIBER ✦

The Cost-Effectiveness of Combined Androgen Blockade With Bicalutamide and Luteinizing Hormone Releasing Hormone Agonist in Men With Metastatic Prostate Cancer

✍ Scribed by Wei, J.T.

Book ID: 122092344
Publisher: Elsevier Science
Year: 2006
Weight: 66 KB
Volume: 2006
Category: Article
ISSN: 0084-4071
DOI: 10.1016/S0084-4071(08)70376-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

THE COST-EFFECTIVENESS OF COMBINED ANDRO

THE COST-EFFECTIVENESS OF COMBINED ANDROGEN BLOCKADE WITH BICALUTAMIDE AND LUTEINIZING HORMONE RELEASING HORMONE AGONIST IN MEN WITH METASTATIC PROSTATE CANCER

✍ PENSON, DAVID F.; RAMSEY, SCOTT; VEENSTRA, DAVID; CLARKE, LAUREN; GANDHI, SANJAY 📂 Article 📅 2005 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 370 KB

Maximal androgen blockade for patients w

Maximal androgen blockade for patients with metastatic prostate cancer: outcome of a controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy

✍ Paul Schellhammer; Roohollah Sharifi; Norman Block; Mark Soloway; Peter Venner; 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 840 KB

865 POSTER Zoledronic acid reduces bone

865 POSTER Zoledronic acid reduces bone loss in men with prostate cancer undergoing androgen blockade with luteinizing hormone-releasing hormone analogues

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 148 KB

897 PUBLICATION Combination therapy with

897 PUBLICATION Combination therapy with bicalutamide 50 mg plus a luteinising hormone-releasing hormone agonist (LHRHa) is cost effective compared with an LHRHa alone in metastatic prostate cancer

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Deferred combined androgen blockade ther

Deferred combined androgen blockade therapy using bicalutamide in patients with hormone-refractory prostate cancer during androgen deprivation monotherapy

✍ YASUHISA FUJII; SATORU KAWAKAMI; HITOSHI MASUDA; TSUYOSHI KOBAYASHI; NOBUHIKO HY 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB

Luteinizing hormone–releasing hormone ag

Luteinizing hormone–releasing hormone agonists in the treatment of men with prostate cancer: timing, alternatives, and the 1-year implant

✍ LEONARD S Marks 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 266 KB